WHO ICTRP trial
A 12 month, phase III, randomized, double-masked, multi-center…
EUCTR2010-021662-30-PT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-021662-30-PT |
|---|---|
| Public title | A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PDT in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia |
| Scientific title | A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PDT in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France;Portugal;Hungary;Slovakia;Spain;Lithuania;Austria;Germany;Latvia;United Kingdom;Italy |
| Conditions | visual impairment due to choroidal neovascularization secondary to pathologic myopia MedDRA version: 12.1 Level: LLT Classification code 10036803 Term: Progressive high (degenerative) myopia MedDRA version: 12.1 Level: LLT Classification… |
| Interventions | Trade Name: Lucentis Product Name: Lucentis Product Code: RFB002F Pharmaceutical Form: Solution for injection INN or Proposed INN: RANIBIZUMAB CAS Number: 347396-82-1 Concentration unit: mg/ml milligram(s)/millilitre Concentration type… |
| Registration date | Aug 30, 2010 |
| Target size | 275 |
| Secondary IDs | CRFB002F2301 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: